Recombinant antigen p30 (SAG1) for Toxoplasma gondii

Ask for quotation or Call me back

Major surface antigen p30 (SAG1) induces significant levels of p30 antibodies in all patients with toxoplasmosis. It has been described in the literature that this 30 kDa protein has the capacity to carry out the serological analysis of Toxoplasma infections.

View more information about Toxoplasmosis.

REFERENCES

RAG0011 (E. coli) WB, DB, Indirect ELISA, positive control in direct ELISA, CLIA, lateral-flow
COA

RAG0019 (P. pastoris) WB, DB, Indirect ELISA, positive control in direct ELISA, CLIA, lateral-flow
COA

RAG0030 (P. pastoris) new

WB, DB, Indirect ELISA, positive control in direct ELISA, CLIA, lateral-flow

CCD SORBENT

As some human normal sera contains IgG antibodies against mannan from various pathogenic Candida species, they can interact with the CCD structures of the proteins produced in Pichia pastoris. With addition of this sorbent, the anti-CCD antibodies will be kidnapped, and the specificity of the assay will increase.

SOR0001

GENE

SAG1

DESCRIPTION

Major surface antigen

PURITY

>95% in a SDS-PAGE

SHIPPING AND STORAGE CONDITIONS

Proteins will be shipped with dry ice or lyophilized. Upon arrival (if liquid), or after reconstitution (if lyophilized), they should be stored at -20ºC to -80ºC. Avoid multiple freeze/thaw cycles

STABILITY

The protein will remain stable for four years if stored frozen

SPECIFICITY

The protein is immunoreactive against seropositive individuals to Toxoplasmosis

IVD

Serodiagnosis of human and animal toxoplasmosis

EVALUATION

SAG1 (p30) from Toxoplasma gondii requires maintain its native conformation to detect IgM antibodies.

PROMOTIONAL MATERIAL

Catalogue
Lyophilised recombinant antigens
Rekom Torch high quality raw material